Globe Roche Logo

Proven Performance

Powered by Nobel-prize winning polymerase chain reaction (PCR) technology, Roche is committed to continued scientific and clinical excellence

Setting the standard in quality

As a leader in molecular diagnostics, Roche continually strives to set and advance standards to give you confidence in our assays and performance in your laboratory.

  • Robust product testing, including more than 250,000 collected data points for the 8 virology assays on our cobas® 4800/6800/8800 Systems1
  • We strive for clinically differentiated assay performance from our
    competitors’ approaches to CE-IVD
  • Our full commitment to quality ensures you will be a trusted partner to
    your customers and ultimately, to patients

Unparalleled performance

Your confidence begins with our commitment to excellence

Each Roche product is designed according to the highest performance standards.

Integrated Control Concept
Timely and comprehensive sample and assay control

Extensive contamination control
Reduced risk of false positives with a minimised risk of carry-over

Leading clinical studies
Trusted results across healthcare—changing the landscape for viral load testing, HPV primary screening, and new advances in oncology testing

State-of-the-art assay design

Through unrivalled investment in research and development, we’re able to stay ahead of rapidly spreading disease in the evolving healthcare paradigm. Our revolutionary assays help to answer key clinical needs:

  • Pioneers of the dual target approach for HIV-1 viral load monitoring
  • Developers of the only clinically validated, FDA-approved and CE-marked assay for first-line, primary screening of cervical cancer
  • Our EGFR assay revolutionises oncology testing, detecting tumour mutations in plasma and FFPE tissue via liquid biopsy/blood draw
  • Real-time detection and discrimination of HIV, HCV, and HBV in a single test in blood donor screening.

Explore

Cross-platform confidence

Roche systems deliver reliable and standardised results that are proven to be comparable across platforms.1*

• Comparable results proven across all platforms1

• Assay performance verified with high precision across platforms for accuracy and traceability according to WHO standards

• No significant difference in the mean titer from system to system at medical decision points

Standardised results across platforms1*
*Standardised for HIV-1, HBV and HCV.

Our commitment to your success

With a long and trusted history of more than 25 years, Roche is proud to offer laboratories like yours, innovative solutions that make a real-world difference. Our goal is to provide you with the solutions you need to consistently and reliably supply top quality results and inform the best patient care possible.

Contact us

Related systems

References

  1. Data on file. RING Trial, 2016.